HODGKIN DISEASE
Clinical trials for HODGKIN DISEASE explained in plain language.
Never miss a new study
Get alerted when new HODGKIN DISEASE trials appear
Sign up with your email to follow new studies for HODGKIN DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo shows promise for Tough-to-Treat lymphoma in youth
Disease control CompletedThis early-phase study tested a combination of two immunotherapy drugs, relatlimab and nivolumab, in 5 children and young adults whose Hodgkin or non-Hodgkin lymphoma had come back or stopped responding to standard treatments. The main goals were to check safety, find the right d…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 26, 2026 08:33 UTC
-
New drug duo shows promise against Hard-to-Treat lymphomas
Disease control CompletedThis study tested a combination of two drugs, favezelimab and pembrolizumab, in 137 people with Hodgkin lymphoma and other B-cell blood cancers. The goal was to see if the combo is safe and shrinks tumors. Some participants received just one of the drugs for comparison. The study…
Matched conditions: HODGKIN DISEASE
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
One donor, two transplants: new hope for patients with blood cancer and kidney failure
Disease control CompletedThis study tested a combined bone marrow and kidney transplant from a partially matched family donor for 10 people with both a serious blood disorder and chronic kidney disease. The goal was to treat both conditions with one donor, potentially reducing the need for lifelong anti-…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated May 18, 2026 12:01 UTC
-
New EHR tool aims to boost heart health talks for cancer survivors
Knowledge-focused CompletedThis study tested a computer tool that helps doctors and cancer survivors discuss heart health during follow-up visits. About 645 survivors of breast, prostate, colorectal, endometrial, and lymphoma cancers took part. The goal was to see if the tool leads to more conversations ab…
Matched conditions: HODGKIN DISEASE
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Wrist wearable tested for heart monitoring in cancer survivors
Knowledge-focused CompletedThis pilot study looked at whether a commercial wrist monitor (WHOOP) can reliably measure resting heart rate and heart rate variability in adults who survived Hodgkin lymphoma after chest radiation. Thirty-four survivors wore the device at home and had in-office measurements for…
Matched conditions: HODGKIN DISEASE
Sponsor: St. Jude Children's Research Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC